MyAverix Finance
US · Healthcare
Swedish Orphan Biovitrum AB (publ) (BIOVF)
Drug Manufacturers - Specialty & Generic
Swedish Orphan Biovitrum AB (publ) (BIOVF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BIOVF
Swedish Orphan Biovitrum AB (publ) (BIOVF) — FAQ
What is BIOVF's P/E ratio?
The price-to-earnings (P/E) ratio for Swedish Orphan Biovitrum AB (publ) (BIOVF) is 18.00 (data as of 2026-03-23).
Does Swedish Orphan Biovitrum AB (publ) pay a dividend?
Dividend yield is not available in the current snapshot for Swedish Orphan Biovitrum AB (publ) (BIOVF). Check the MyAverix Finance app for the latest dividend data.
What sector is Swedish Orphan Biovitrum AB (publ) in?
Swedish Orphan Biovitrum AB (publ) (BIOVF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is BIOVF listed on?
BIOVF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.